All cholesterol-lowering interventions are expected to reduce stroke: Confirmatory data from IMPROVE-IT
The relationship of cholesterol with stroke is much less clear than its relationship with myocardial infarction, thus confounding the interpretation of results with cholesterol-lowering trials (Di Napoli et al., 2002) [1], (De Caterina et al., 2010) [2]). IMPROVE-IT data ((Cannon et al. 2015) [3]),...
Main Authors: | Raffaele De Caterina, Tanya Salvatore, Roberto Marchioli |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-06-01
|
Series: | Data in Brief |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352340916302736 |
Similar Items
-
Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients
by: Nicolas Poupore, et al.
Published: (2020-05-01) -
Prevention of stroke: Antihypertensives, cholesterol-lowering drugs, antithrombotics, anticoagulation, carotid surgery, and stenting
by: Michael Brainin
Published: (2018-01-01) -
Validity and reliability of the Farsi version of Wijma delivery expectancy questionnaire: an exploratory and confirmatory factor analysis
by: Forough Mortazavi
Published: (2017-06-01) -
Nonpharmacological cholesterol-lowering approach: Managing cholesterol naturally
by: Lubna Mahmood
Published: (2015-01-01) -
Frequent cholesterol feedback as an aid in lowering cholesterol levels
by: Burkett, Paul A.
Published: (2014)